Phase I study of immunotherapy with methanol extraction residue of BCG (MER) administered by the intravenous (IV) route
- 31 December 1980
- journal article
- abstracts
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 2 (3) , 159-160
- https://doi.org/10.1016/0192-0561(80)90055-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: